Biomimetic Nanodisks Are Effective Against Tubulointerstitial Fibrosis via Targeting Interstitial Microenvironment

Author:

Zhou Chuchu12ORCID,Tang Rou1,Tan Huajin1,Yang Yige1,Meng Peipei34,Li He5,Song Kaichao16,Tan Xiaochuan1ORCID,Guo Xiuping6,Ren Ling6,He Shuwang7,Meng Ya1,Hao Yumei1,Lin Mingbao1,Zhang Yujia1,Huang Hongdong3,Wang Lulu6ORCID,Zheng Wensheng1ORCID

Affiliation:

1. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Union Medical College, China.

2. Clinical Research Center, Beijing Children’s Hospital, National Center for Children’s Health (C.Z.), Capital Medical University, China.

3. Department of Nephrology, Beijing Friendship Hospital, Faculty of Kidney Diseases (P.M., H.H.), Capital Medical University, China.

4. Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing (P.M.).

5. Beijing Tiantan Hospital (H.L.), Capital Medical University, China.

6. Institute of Medicinal Biotechnology (K.S., X.G., L.R., L.W.), Chinese Academy of Medical Sciences and Peking Union Medical College, China.

7. Shandong DYNE Marine Biopharmaceutical Co, Ltd, Rongcheng, China (S.H.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3